Please help to provide your analysis on the 5 companies performances against Pfizer and also in pharmaceutical industry

Bristol- Johnson Pfizer Merck Novartis Myers & Squibb Johnson Research over Revenue % 15.74 16.97 17.73 35.79 12.91 Revenue INR MI 48,851 39,498 Mil 50,387 16,560 70,074 Gross Margin % 80.3 62.2 65.5 76.4 69.3 Operating Income INR Mil 11,824 6,928 8,977 1,890 18,065 Operating Margin % 24.2 17.5 17.8 11.4 25.8 Net Income INR Mil 6,960 4,442 17,783 1,565 15,409 Earnings Per Share INR 1.11 1.56 7.29 0.93 5.48 Dividends INR 1.12 1.81 2.67 1.49 2.95 Payout Ratio % 82.7 48.4 77.7 139.6 55.6 Shares Mil 6,257 2,841 2,403 1,679 2,813 Book Value Per Share INR 10.82 16.39 32.31 9.08 25.86 Operating Cash Flow INR Mil 14,512 12,421 11,897 1,832 19,279 Cap Spending INR Mil -1,496 -1,283 -3,505 -820 -3,463 Free Cash Flow INR Mil 13,016 11,138 8,392 1,012 15,816 Free Cash Flow Per Share INR 2.22 1.65 3.97 0.64 5.3 Working Capital INR MI 14,405 10,561 -863 2,398 32,463 Tax Rate % 22.2 17.44 13.6 21.47 19.73 Net Margin % 14.25 11.25 35.29 9.45 21.99 Asset Turnover (Average) 0.29 0.39 0.39 0.51 0.53 Return on Assets % 4.13 4.44 13.84 4.78 11.65 Financial Leverage (Average) 2.59 2.28 1.71 2.23 1.88 Return on Equity % 10.24 9.52 24.06 10.75 21.87 Return on invested Capital % 7.11 6.74 19.28 7.83 17.55 Interest Coverage 8.48 9.04 13.16 12.29 35.78 Source: Morningstar.com